Association of Clinical Phenotypes in Haploinsufficiency A20 (HA20) With Disrupted Domains of A20

Yu Chen(Jiangnan University), Fang Xiao(Tongji Hospital), Dean Tian(Tongji Hospital), Tingting Qin(Tongji Hospital), Liping Chen(Dongfeng Motor Group (China)), Zhenghao Ye(Medizinische Hochschule Hannover), Ursula Seidler(Medizinische Hochschule Hannover)

Frontiers in Immunology

September 23, 2020

10.3389/fimmu.2020.574992

Cited by 57

Related Papers

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

|New England Journal of Medicine|2016|1.8k

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity

|PLoS ONE|2007|478

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

|The Lancet|2021|452

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

|The Lancet|2017|449

Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase II

|Science|1996|409